CRS To Supply MDS Proteomics With Leading Edge Robotic Systems For High Throughput Proteomics Research & Development.Business Editors & Health/Medical Writers BIOWIRE2K BURLINGTON, Ontario--(BW HealthWire)--Jan. 30, 2001 CRS Robotics CRS Robotics Corporation (now Thermo CRS Limited) was a robotics company based out of Burlington, Ontario, Canada. CRS Robotics designed, manufactured, distributed, and serviced human scale robots and laboratory automation systems. Corporation (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :ROB.) announced today that MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Proteomics has entered into a supply agreement to use CRS's proprietary automated protein expression platforms. These fully automated systems will increase the throughput of MDS Proteomics' systems. CRS CRS Course CRS Certified Residential Specialist (real estate certification) CRS Central Reservation System CRS Can't Remember Stuff (polite form) CRS Cost Reduction Strategy CRS Consumer Relations Specialist , well known for its early involvement in the genomics research field, is poised to dominate the newly developing proteomics field for highly sophisticated automation tools with a broad range of automation products and solutions. CRS President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Ralph Steedman said, "CRS is happy to be chosen as a solutions partner for MDS Proteomics and is looking forward to continuously supplying automation tools and consultantcy support to their team of high caliber scientists." Dr. Mark Pearson
Mark "Pancho" Pearson, (born in October 28, 1939 in Ridgeway), was an English football forward. Pearson started his professional career with Manchester United F.C.. , Senior Vice-President, Research and Bioinformatics of MDS Proteomics commented: "CRS's experience in high throughput screening and acknowledged leadership in automating difficult genomics protocols enabled it to consult on and offer the most up-to-date hardware and software solutions. We were impressed with the high calibre of engineering and scientific specialists at CRS." CRS has been acknowledged as one of the few companies on the forefront of laboratory automation technology. Core competencies of the company include integrated lab automation solutions using advanced software in biotechnology and pharmaceutical research applications marketed worldwide. In addition, CRS manufactures and supplies robotic systems for advanced manufacturing niche markets. CRS is headquartered in Burlington, Ontario Burlington (2006 population 164,415) is a city located in the Golden Horseshoe, across Lake Ontario and Burlington Bay harbour from Hamilton, in Halton Region, Ontario, Canada. and has subsidiaries in the United States and Europe. Further information can be found on the company's web site at www.crsrobotics.com. Some of the matters discussed in this news release involve risks and uncertainties, which include, but are not limited to, risks and uncertainties regarding the Company's ability to generate high growth sales rates and uncertainties related to economic conditions, markets, products, competition, intellectual property, services and prices, key employees and future capital needs that the company depends on. Additional information on these and other potential factors that could effect the Company's financial results are detailed in documents filed from time to time with the Ontario Securities Commission The Ontario Securities Commission (OSC) is a regulatory agency which administers and enforces securities legislation in the Canadian province of Ontario. The OSC is an Ontario Crown corporation which reports to the Ontario legislature through the Minister of Finance. . The Company undertakes no responsibility to update forward -looking statements if circumstances or management's projections, beliefs or opinions change. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion